Bayesian Capital Management, LP Teva Pharmaceutical Industries LTD Transaction History

Bayesian Capital Management, LP

$854 Million
Q2 2024

A detailed history of Bayesian Capital Management, LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bayesian Capital Management, LP holds 34,100 shares of TEVA stock, worth $596,750. This represents 0.06% of its overall portfolio holdings.

Number of Shares

34,100

Holding current value

$596,750

% of portfolio

0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $435,798 - $593,340	34,100 New	34,100 $554,000
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $328,548 - $446,840	39,300 New	39,300 $347,000
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $307,008 - $432,640	-41,600 Reduced 52.99%	36,900 $277,000
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $575,405 - $737,115	78,500 New	78,500 $737,000
Q2 2021 Aug 13, 2021	SELL	$9.9 - $11.56 $313,830 - $366,452	-31,700 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$10.34 - $12.81 $951,280 - $1.18 Million	-92,000 Reduced 74.37%	31,700 $366,000
Q4 2020 Feb 12, 2021	SELL	$8.61 - $11.04 $65,435 - $83,904	-7,600 Reduced 5.79%	123,700 $1.19 Million
Q3 2020 Nov 12, 2020	BUY	$8.57 - $12.69 $602,471 - $892,107	70,300 Added 115.25%	131,300 $1.18 Million
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $732,423 - $1.18 Million	-90,200 Reduced 59.66%	61,000 $752,000
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $1.01 Million - $2.03 Million	151,200 New	151,200 $1.36 Million
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $774,729 - $1.27 Million	-53,100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $1.12 Million - $1.36 Million	53,100 New	53,100 $1.14 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account

Bayesian Capital Management, LP Teva Pharmaceutical Industries LTD Transaction History